Breast and Ovarian Cancer Genomics
1 – 10 of 90
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
- Contribution to journal › Article
-
Mark
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
- Contribution to journal › Article
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
(2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
-
Mark
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
- Contribution to journal › Article
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
- Contribution to journal › Article
-
Mark
Global Transcriptional Complexity of Estrogen Receptor Low Positive Breast Cancers in a Prospective Swedish Population-based SCAN-B Cohort
(2025) In Clinical cancer research : an official journal of the American Association for Cancer Research 31(13). p.2695-2709
- Contribution to journal › Article
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
- Contribution to journal › Article
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
- Contribution to journal › Article
